Heyan Li

Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by &agr;1 Nicotinic Acetylcholine Receptor–Mediated Activation in PC9 Cells

Y. Nakanishi, K. Takayama, Kentaro Tanaka, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes

W. Zhou, Caicun Zhou, L. Tang, 2010, Nanotechnology.

Lorlatinib for Previously Treated ALK -Positive Advanced NSCLC: Primary Ef fi cacy and Safety From a Phase 2 Study in People ’ s Republic of China

C. Bai, He-long Zhang, Jian-hua Chang, 2022 .

Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression

Y. Nakanishi, K. Takayama, I. Okamoto, 2014, Cancer Chemotherapy and Pharmacology.

Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR‐tyrosine kinase inhibitors

G. Giaccone, Y. Nakanishi, K. Takayama, 2013, Cancer science.

Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model.

Y. Nakanishi, K. Takayama, I. Okamoto, 2015, Lung cancer.

RGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studies.

W. Zhou, Caicun Zhou, L. Tang, 2011, European journal of radiology.

Lorlatinib for Previously Treated ALK-Positive Advanced Non-Small Cell Lung Cancer: Primary Efficacy and Safety From a Phase 2 Study in China.

Ying Cheng, C. Bai, He-long Zhang, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines.

Daoyuan Wang, Caicun Zhou, Songwen Zhou, 2013, Cancer biotherapy & radiopharmaceuticals.

Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression

Y. Nakanishi, K. Takayama, I. Okamoto, 2014, Cancer Chemotherapy and Pharmacology.